Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.545 USD | +2.36% | +8.03% | -18.08% |
May. 06 | Sagimet Biosciences Names Thierry Chauche CFO | MT |
May. 06 | Sagimet Biosciences Inc. Announces Appointment of Thierry Chauche as Chief Financial Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 142M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -115M | EV / Sales 2024 * | - |
Net cash position 2024 * | 142M | Net cash position 2025 * | 217M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.04
x | P/E ratio 2025 * |
-1.12
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.59% |
1 day | +2.54% | ||
1 week | +8.03% | ||
Current month | +13.85% | ||
1 month | -17.47% | ||
3 months | -26.00% | ||
6 months | +26.50% | ||
Current year | -18.08% |
Managers | Title | Age | Since |
---|---|---|---|
David Happel
CEO | Chief Executive Officer | 62 | 22-10-23 |
George Kemble
CHM | Chairman | 63 | 11-08-14 |
Elizabeth Rozek
CMP | Compliance Officer | 53 | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 07-03-31 |
Richard Rodgers
BRD | Director/Board Member | 57 | 15-02-28 |
Director/Board Member | 60 | 21-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 4.44 | +2.54% | 312 845 |
24-05-07 | 4.33 | +1.17% | 288,054 |
24-05-06 | 4.28 | -0.93% | 559,222 |
24-05-03 | 4.32 | -2.92% | 770,647 |
24-05-02 | 4.45 | +8.27% | 1,127,748 |
End-of-day quote Nasdaq, May 07, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.08% | 142M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- SGMT Stock